News

The genetic information is transcribed and subsequently translated into functional proteins. ...
Moderna (MRNA) stock in focus as the company cancels plans for an mRNA manufacturing plant in Japan amid a challenging ...
Moderna said on Friday it is cancelling plans to build a messenger RNA manufacturing plant in Japan due to "changes in the ...
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside ...
Moderna Japan had planned to build an mRNA drug plant at Shonan Health Innovation Park in Kanagawa prefecture. The company shelved the plan, citing weak demand for vaccines and a poor business ...
Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...
How does a cell know when it’s been damaged? A molecular alarm, set off by mutated RNA and colliding ribosomes, signals ...
Because they rely on hosts for a majority of functions, viruses aren’t considered alive. But entities like this one ...
The deal, announced on June 30, will advance a subsect of research into new autoimmune treatments that began at Penn.
Study reveals how cells regulate repair protein production to prevent DNA damage over-repair or under-repair, aiding cell ...
The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...
Moderna is expected to announce its second-quarter results in the upcoming month, and analysts expect a slight reduction in ...